Nathali Kaushansky

Weizmann Institute of Science — Israel

Medicine · Health Sciences

23h-index2.1kcitations74works3.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(23), Immunotherapy and Immune Responses(13), T-cell and B-cell Immunology(12), Immune Cell Function and Interaction(12), Hematopoietic Stem Cell Transplantation(10)

Publications74 total

Deciphering the origin and plasticity of circulating endothelial cells reveals a systemic angiogenic program in breast cancer
Blood·2025Open Access
A founder heterozygous mutation in Methyl-CpG binding domain protein 4 (MBD4) prevalent among Israeli Christian Arabs predisposes to increased mutagenesis
Haematologica·2025· 1 citedOpen Access
Deciphering the Origin and Plasticity of Circulating Endothelial Cells: A Model for Systemic Angiogenesis Programs in Health and Disease
2025Open Access
A reference model of circulating hematopoietic stem cells across the lifespan with applications to diagnostics
Nature Medicine·2025· 6 citedOpen Access
Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice
Cell Reports·2025· 13 citedOpen Access
Utilizing insights of DNA repair machinery to discover MMEJ deletions and novel mechanisms
Nucleic Acids Research·2024· 2 citedOpen Access
Targeting SRSF2 mutations in leukemia with RKI-1447: A strategy to impair cellular division and nuclear structure
iScience·2024· 5 citedOpen Access
Age-related micro-environmental changes as drivers of clonal hematopoiesis
Current Opinion in Hematology·2023· 5 cited
Natural and age-related variation in circulating human hematopoietic stem cells
2023· 1 citedOpen Access
Monocyte-derived microglia with <i>Dnmt3a</i> mutation cause motor pathology in aging mice
2023· 8 citedOpen Access
The ELN 2022 Risk Stratification Has No Impact on the Dismal Prognosis of Patients with Acute Undifferentiated Leukemia
Blood·2023
The Presence of Somatic Mutation in Donor Does Not Affect Long-Term Outcomes in 339 Patients Following Allogeneic Hematopoietic Stem Cell Transplantation Using Uniform Fludarabine/Busulfan Myeloablative Conditioning and Cyclosporine/Methotrexate and ATG Gvhd Prophylaxis
Blood·2023Open Access
Inflammatory signals from fatty bone marrow support DNMT3A driven clonal hematopoiesis
Nature Communications·2023· 52 citedOpen Access
The role of RNF149 in the pre-emptive quality control substrate ubiquitination
Communications Biology·2023· 7 citedOpen Access
Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up
Haematologica·2023· 16 citedOpen Access
RKI-1447, a ROCK Inhibitor, Targets SRSF2 Mutated Leukemia by Disrupting Cell Mitosis and Nuclear Morphology
SSRN Electronic Journal·2023Open Access
DNA Methylation is stable after MMEJ and NHEJ double strand break repair
2022Open Access
S122: ROCK INHIBITORS TARGET SRSF2 LEUKEMIA BY DISRUPTING CELL MITOSIS AND NUCLEAR MORPHOLOGY
HemaSphere·2022Open Access
Pseudo-mutant P53 is a unique phenotype of &lt;i&gt;DNMT3A&lt;/i&gt;-mutated pre-leukemia
Haematologica·2022· 11 citedOpen Access
Rock inhibitors target <i>SRSF2</i> leukemia by disrupting cell mitosis and nuclear morphology
2022Open Access
page 1 of 4Next →

Frequent Co-authors

Avraham Ben‐Nun(23), Liran I. Shlush(15), Noa Chapal-Ilani(7), Ewa Kozela(6), Ana Juknat(6), Zvi Vogel(6), Mark D. Minden(6), Miriam Eisenstein(5), Rina Zilkha‐Falb(5), Yoni Moskovitz(5), Marina Scheller(4), Carsten Müller‐Tidow(4), Hans Lassmann(4), Tamir Biezuner(4), Noa Chapal Ilani(4), Yardena Brilon(4), Eszter Bakos(3), Shirly Becker-Herman(3), Idit Shachar(3), Michal Rivlin‐Etzion(3)